STAT+: Fresh turmoil roils American Diabetes Association following controversy at conference

STAT PlusExclusive Fresh turmoil roils American Diabetes Association following controversy at conference Group cites ongoing review in blocking journal from publishing an editorial, members’ accounts of expulsion Manage alerts for this article Email this article Share this article By Elizabeth CooneyJuly 16, 2026 Cardiovascular Disease Reporter Elizabeth Cooney[email protected]Liz covers cardiovascular and metabolic disease, asking why we’re not doing better or even losing ground against the world’s leading killer. Send tips on Signal at LizC.22. Turmoil at the American Diabetes Association has taken a fresh turn, with leaders blocking editors at its flagship journal from publishing an opinion piece and first-person accounts detailing a high-profile controversy at the group’s own annual meeting just last month. Nearly five weeks after five diabetes specialists were escorted out of a conference center in New Orleans for handing out reprints of an editorial expressing concern over cuts to federal research, the ADA’s flagship journal, Diabetes Care, was preparing to publish an editorial and several accounts detailing the episode, which drew national attention and prompted the ADA to both apologize for the evictions and pledge a formal review. But the organization says it delayed publication pending the outcome of that review — even as there is disagreement about how it is being carried out.Advertisement In the spiked editorial and personal accounts, now available on an open-access website, the diabetes specialists who were ejected in early June detail their treatment. Prominent ADA members, including past leaders and one who resigned in the wake of the confrontation, also express dismay over how the events were handled initially and afterward. All voice disappointment over the decision to suppress views opposing policies of the Trump administration while also disagreeing with how ADA’s leadership handled the episode and its aftermath. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? Log in Monthly $39 Totals $468 per year $39/month Get Started Totals $468 per year Starter $30 for 3 months, then $399/year $30 for 3 months Get Started Then $399/year Annual $399 Save 15% $399/year Get Started Save 15% 11+ Users Custom Savings start at 25%! Request A Quote Request A Quote Savings start at 25%! 2-10 Users $300 Annually per user $300/year Get Started $300 Annually per user View All Plans To read the rest of this story subscribe to STAT+. Subscribe Log In diabetes, NIH, research, STAT+ Submit a correction requestReprints Elizabeth Cooney Cardiovascular Disease Reporter Liz covers cardiovascular and metabolic disease, asking why we’re not doing better or even losing ground against the world’s leading killer. Send tips on Signal at LizC.22. Newsletter Understand how science, health policy, and medicine shape the world every day Recommended Exclusive July 15, 2026 STAT Plus: Medicare Advantage insurers face new bipartisan scrutiny over AI and care denials Exclusive July 15, 2026 STAT Plus: Under a new leader, the FDA’s biologics center moves to steady itself after stormy chapter Advertisement Exclusive July 14, 2026 STAT Plus: Top Democrats question RFK Jr.’s health care advisory panel Exclusive July 13, 2026 STAT Plus: HHS presses ahead with effort to curb antidepressant use Exclusive July 10, 2026 Nominee for key federal health role has a history of questioning vaccines Subscriber Picks